Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment.

Suppr

超能文献

作者信息

Erickson Stephen P, Nahmias Zachary, Rosman Ilana S, Sternhell-Blackwell Kara, Musiek Amy C

机构信息

Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.

出版信息

JAAD Case Rep. 2018 Feb 28;4(3):245-247. doi: 10.1016/j.jdcr.2018.01.012. eCollection 2018 Apr.

DOI:10.1016/j.jdcr.2018.01.012

PMID:29687061

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5909489/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef6/5909489/385aadb5cd23/gr1.jpg

相似文献

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment.

JAAD Case Rep. 2018 Feb 28;4(3):245-247. doi: 10.1016/j.jdcr.2018.01.012. eCollection 2018 Apr.

[Cutaneous lymphocytoma (lymphadenosis benigna cutis)].

Rass Clin Sci. 1960 Sep;36:241-6.

A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis.

Hum Pathol. 2005 May;36(5):505-11. doi: 10.1016/j.humpath.2005.02.012.

[A new case of lymphadenosis benigna cutis (lymphocytoma)].

Actas Dermosifiliogr. 1951 Feb;42(5):503-4.

Recalcitrant lymphocytoma cutis successfully treated with mycophenolate mofetil.

SAGE Open Med Case Rep. 2021 Jun 14;9:2050313X211025104. doi: 10.1177/2050313X211025104. eCollection 2021.

Lymphocytoma cutis: diagnostic enigma for the maxillofacial surgeon.

J Korean Assoc Oral Maxillofac Surg. 2016 Dec;42(6):379-382. doi: 10.5125/jkaoms.2016.42.6.379. Epub 2016 Dec 27.

[Dermatologic findings in Lyme-Borreliosis. 4. Borrelia lymphocytoma (lymphadenosis cutis benigna Bäferstedt)].

Fortschr Med. 1997 Nov 30;115(33):46-8.

[Differentiation of lymphadenosis non follicularis benigna cutis from skin manifestation of chronic lymphadenosis].

Dermatol Wochenschr. 1952;126(47-48):1146-56.

Borrelia lymphocytoma ("lymphadenosis benigna cutis").

Arch Dis Child. 2002 Jul;87(1):12. doi: 10.1136/adc.87.1.12.

Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination.

Dermatology. 2010;220(2):176-9. doi: 10.1159/000269845. Epub 2009 Dec 23.

引用本文的文献

Clinical and Histopathological Characteristics of Cutaneous Lymphoid Hyperplasia: A Comparative Study According to Causative Factors.

J Clin Med. 2020 Apr 23;9(4):1217. doi: 10.3390/jcm9041217.

本文引用的文献

A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders.

Trends Mol Med. 2017 Apr;23(4):348-361. doi: 10.1016/j.molmed.2017.02.006. Epub 2017 Mar 10.

Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma?

Indian J Dermatol. 2016 Jul-Aug;61(4):351-74. doi: 10.4103/0019-5154.185698.

Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions.

J Am Acad Dermatol. 2016 Jul;75(1):210-2. doi: 10.1016/j.jaad.2016.03.022.

Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination.

Dermatology. 2010;220(2):176-9. doi: 10.1159/000269845. Epub 2009 Dec 23.

Drug-associated lymphoma and pseudolymphoma: recognition and management.

Dermatol Clin. 2007 Apr;25(2):233-44, vii. doi: 10.1016/j.det.2007.01.008.

Cutaneous lymphoid hyperplasias.

Semin Cutan Med Surg. 2000 Jun;19(2):133-41. doi: 10.1016/s1085-5629(00)80011-5.

Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):1005-7. doi: 10.1016/s0190-9622(99)70094-0.

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.

J Am Acad Dermatol. 1996 Dec;35(6):969-79. doi: 10.1016/s0190-9622(96)90122-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验